BGI Group

BGI Group BGI was founded privately in 1999 to participate in the renowned Human Genome Project.

BGI Group, a pioneer in life sciences, is one of the world’s leading biotechnology organizations with operations covering research, production, and applications in more than 100 countries and regions. It expanded scope through news business since 2007 and now it supports the genomics-related project with customers across the world.

05/01/2026

Physical activity is a cornerstone of health, and at ICG-20 Hangzhou, Professor Vassilis Klissouras (University of Athens & McGill University) shared groundbreaking insights into its impact on aging and disease prevention.

Even 15-20 minutes of movement a week can significantly lower cardiovascular risks, improve cognitive function, and boost immunity. Professor Klissouras also discussed the role of AI in analyzing data and advancing research into aging and health.

The ICG platform continues to drive global collaboration and innovation, bridging genomics, AI, and health science for a better tomorrow.



How has physical activity shaped your health journey? Share your thoughts!

31/12/2025

Professor Roland Eils (BIH & Fudan University) shares a profound vision for the future of healthcare! He explains how combining AI, multi-omics, and vast health data is moving us from reactive treatment to personalized preventive medicine, predicting disease risks much earlier. Eils highlights that multi-omics technology, once exclusive, is now accessible to everyone, and credits BGI Group for being instrumental in bringing high-quality, low-price omics to a global scale. This marks a crucial turning point for health worldwide! What are your thoughts on this predictive, preventive future?

29/12/2025

AI and genomics are transforming the future of healthcare. At ICG-20 Hangzhou, Professor Xiangdong Wang (Fudan University) shared how cutting-edge innovations like the Stereo-cell project and the AI Genos model are advancing precision medicine.

These technologies enable deeper, multi-dimensional insights into diseases, faster clinical applications, and significant progress in disease prevention. Professor Wang highlighted BGI’s role in leading these breakthroughs, fostering collaboration, and driving progress across the globe.

What excites you most about the integration of AI and genomics? Share your thoughts below!

26/12/2025

Facing a diagnosis of Retinoblastoma is terrifying for any family, as it often means the risk of a child losing their vision. But Dr. Lai Poh San, Head of Human Molecular Genetics Laboratory at National University of Singapore (NUS), shares an inspiring message about how science is fighting back. She describes how continuous improvements in technology—ranging from targeted sequencing to whole-genome and single-cell sequencing—are helping doctors understand the disease better than ever before. This deeper knowledge is the key to early detection and developing future treatments that are effective but less aggressive, protecting both the health and the eyesight of children.

Understanding where DNA in our blood comes from is key to diagnosing diseases early. However, traditional methods can be...
25/12/2025

Understanding where DNA in our blood comes from is key to diagnosing diseases early. However, traditional methods can be costly and complex.

Researchers at BGI-Research have developed a solution called the Tissue Contribution Index (TCI). Published in Communications Biology, this method uses a unique biological feature—open chromatin footprints—to trace tissue origins more efficiently and affordably.

From prenatal testing to cancer detection, the study validates TCI as a robust tool for diverse clinical needs.

Learn more about the study here: https://en.genomics.cn/en-scientificdiscoverie-7450.html

24/12/2025

Have you heard about the Protein Atlas?At ICG-20 Hangzhou, Professor Mathias Uhlén from KTH Royal Institute of Technology shared his groundbreaking work on this open-access project, which maps all human proteins through 12 million images and 5 million web pages. This incredible resource is helping scientists worldwide better understand human biology and develop life-changing drugs.

Professor Uhlén highlighted the vital role of AI and innovative tools like BGI Stereo-seq in analyzing this data for future breakthroughs. He also commended BGI Group for their commitment to advancing life sciences and fostering global collaboration.

The next decade of AI-driven science starts here! 🌟



What excites you most about the future of science? Share your thoughts below!

A fascinating new multi-institutional study led by BGI-Research, Sun Yat-sen University, and others published in Nature ...
23/12/2025

A fascinating new multi-institutional study led by BGI-Research, Sun Yat-sen University, and others published in Nature Communications has mapped the hidden world of germs inside rats and shrews living near humans in Southern China. Researchers analyzed over 800 animals using advanced sequencing and discovered 76 different potential pathogens, showing that while guts are full of viruses, lungs are unexpectedly rich in parasites. This work identifies common species like the Brown rat as major disease "hubs," providing scientists with crucial data to better understand transmission routes and prevent future outbreaks in our communities.

Read the full study: https://en.genomics.cn/en-scientificdiscoverie-7412.html

22/12/2025

Speaking at ICG-20 Hangzhou, Frederick C. Dubee, Co-chair of the ICG International Advisory Board and Former Senior Advisor to the United Nations Global Compact, emphasized the importance of ethics and openness in science. He highlighted how BGI’s commitment to global collaboration and open sharing has driven transformative advancements in genomics, benefiting people worldwide.

Dubee reflected on the need for shared values and teamwork across disciplines and borders, which remain central to ICG’s mission.

Science thrives on collaboration—what values do you think are key to meaningful innovation? Share your thoughts below.

We are grateful to announce that two scientific collaborations launched by BGI Group have been endorsed by UNESCO as pro...
18/12/2025

We are grateful to announce that two scientific collaborations launched by BGI Group have been endorsed by UNESCO as projects under the United Nations International Decade of Sciences for Sustainable Development (2024-2033).

This recognition highlights the collective effort of scientists worldwide to use science for the greater good.

🧬 Making Health Accessible: The Human Genome Project II (HGP2) is working to ensure that precision medicine becomes a public good accessible to all. Supported by an editorial article in Cell Research by scientists from 14 countries, the project aims to help people lead healthier lives regardless of where they are born.

🔬 Strengthening Health Systems: The African Microbiome Consortium for Infectious Diseases (AMC-ID) is dedicated to tackling infectious diseases like malaria and tuberculosis. By leveraging microbiomics and the "One Health" approach, it aims to build sustainable, localized technology platforms and talent pipelines in Africa.

These projects represent a shared vision: bringing cutting-edge technology from the laboratory into public health to build a safer, more prosperous future for everyone.

Thank you to our partners in over 60 countries who make this work possible.

https://en.genomics.cn/en-news-7400.html

17/12/2025

At ICG-20 Hangzhou, Dr. Claude Mambo Muvunyi shared how the partnership between the Rwanda Biomedical Centre and BGI is helping to improve cervical cancer screening.

With BGI’s donation of 20,000 HPV tests, Rwanda is scaling up DNA testing and introducing self-test kits to make screening more accessible and cost-effective. These efforts are supporting Rwanda’s ambitious goal to eliminate cervical cancer by 2027, ahead of the WHO’s 2030 target.

This collaboration highlights the important role partnerships play in advancing public health.

What are your thoughts on the role of collaboration in healthcare? Share below!

16/12/2025

🌟 MasterPlan: AI水上無人船 × 華大創新實驗室 – 現正招生!

課程亮點:
🚤 設計與建造AI智能無人船,融合3D列印與物理原理
🧬 進入真實基因組學實驗室,探索水生生物多樣性與保育

📌 適合年級:4–9年級
🗓️ 選擇您的課程時間:
- 2025年12月22日–28日
- 2026年2月2日–8日

📍深圳
名額有限
📧 聯絡方式:yuanguang@genomics.cn

16/12/2025

🌟 MasterPlan: AI Unmanned Surface Vessel × BGI College Innovation Lab – Enrollment Open!

Course Highlights:
🚤 Design & build AI-powered unmanned boats, combining 3D printing and physics
🧬 Step into a real genomics lab to explore aquatic biodiversity and conservation

📌 Designed for: Grades 4–9
🗓️ Choose Your Session:
-Session 1: Dec 22–28, 2025
-Session 2: Feb 2–8, 2026

📍Shenzhen, China
Limited seats available
📧 Contact: yuanguang@genomics.cn

Address

Building 11, Beishan Industrial Zone, Yantian District
Shenzhen
518083

Alerts

Be the first to know and let us send you an email when BGI Group posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to BGI Group:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram